Article Details

Boston Scientific CEO Mike Mahoney talks Lotus decision, post-COVID outlook

Retrieved on: 2020-12-01 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

Boston Scientific CEO Mike Mahoney talks Lotus decision, post-COVID outlook. View article details on hiswai:

Excerpt

“Essentially, the cost to invest to further advance the Lotus device and its delivery ... The system's annular sealing technology also minimizes paravalvular ... 3M Medical Materials & Technologies Great <b>medical devices</b> start with an ...

Article found on: www.massdevice.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up